Trump Media & Technology 株価情報 (NASDAQ: DJTWW)

最新ニュース Trump Media & Technology (NASDAQ:DJTWW) 株価情報

Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest global conversation without discriminating against political ideology.

Mid Cap

News

Movers

CRDO

DJTWW

ENVX

FIZZ

GLBE

GRND

KVYO

STAA

TGLS

先週、これらの中型株は最も優れた業績を発揮しました。あなたのポートフォリオには含まれていますか？

中小株式市場　今週注目の10銘柄

Trump Media & Technology Group Corp. - Warrants

Trump Media & Technology Group Corp

Flora Farms, a prominent cannabis producer in Missouri, voluntarily recalled over 3,000 Zen-brand cannabis gummies last month after state regulators flagged a <a href="https://www.benzinga.com/cannabis">labeling oversight. </a>
The issue? The ingredient list omitted the specific food coloring used in the gummies, Missouri Independent <a href="https://missouriindependent.com/briefs/labeling-error-led-to-missouri-recall-of-cannabis-gummies/">reported.</a>
<h3 class="wp-block-heading">A Regulatory Reminder</h3>
According to Sami Jo Freeman, spokeswoman for Missouri's Division of Cannabis Regulation (DCR), the recall stemmed not from the food coloring itself, which is not banned, but from the omission on the ingredients list.
See Also: <a href="https://www.benzinga.com/24/12/42300451/nasdaq-listed-high-tide-under-the-magnifying-glass-key-insights-for-cannabis-investors">NASDAQ-Listed High Tide Under The Magnifying Glass: Key Insights For Cannabis Investors</a>
"Food coloring must be disclosed in the ingredient list in order to be used in a product," Freeman explained. "This helps consumers know that if they have an allergy to it, that they should not consume that product."
Only one adverse reaction was reported and the incident did not require hospitalization.
<h3 class="wp-block-heading">Cannabis&#8217; Compliance Challenges</h3>
The recall occurred despite <a href="https://www.benzinga.com/topic/missouri-cannabis">Missouri's newly implemented recreational marijuana </a>packaging and labeling rules. Since Sept. 1, manufacturers have been required to submit packaging and labels for pre-approval by the DCR before products reach dispensary shelves. 
However, this process focuses more on design compliance such as ensuring information is included and packaging is not appealing to children, rather than on verifying the accuracy of ingredient lists.
"Verification of whether information is accurate occurs through other processes, such as inspections, complaints, and investigations," Freeman clarified.
Missouri's rules mandate that cannabis packaging feature plain designs with limited colors and minimal branding. These measures aim to comply with the state's constitutional requirement that marijuana-related product packaging "shall not be made to be attractive to children."
Mark Hendren, president of Flora Farms, replied. "DCR requested that Zen labels more specifically identify the food coloring used. So that's what we have done."
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42299396/the-state-of-nebraska-is-pushing-back-against-cannabis-both-locally-and-nationally">Nebraska&#8217;s Two-Front War On Cannabis</a></li>
</ul>
Cover image made with AI.

Cannabis

Regulations

Markets

Why This Cannabis Company Recalled Over 3,000 Gummies In Missouri

Analysts' ratings for Interactive Brokers Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) over the last quarter vary from bullish to bearish, as provided by 8 analysts.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $167.75, along with a high estimate of $195.00 and a low estimate of $155.00. This upward trend is apparent, with the current average reflecting a 8.31% increase from the previous average price target of $154.88.
<img src="https://www.benzinga.com/files/images/story/2024/1733259610_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of Interactive Brokers Gr by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Yaro</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$195.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$165.00</td>
<td>$166.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$170.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$163.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$166.00</td>
<td>$147.00</td>
</tr>
<tr>
<td>Daniel Fannon</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$165.00</td>
<td>$152.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$155.00</td>
<td>$145.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Interactive Brokers Gr. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Interactive Brokers Gr compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Interactive Brokers Gr's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Interactive Brokers Gr's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/IBKR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Interactive Brokers Gr analyst ratings.</a>
<h2>About Interactive Brokers Gr</h2>
Interactive Brokers is an online brokerage that generates trading commissions (around 31% of net revenue) from facilitating trading in a wide range of products, including equity, options, futures, foreign exchange, bonds, mutual funds, and exchange-traded funds. Interactive Brokers also generates net interest income (about 64% of net revenue) from idle client cash and earns fees (about 6% of net revenue) from ancillary services. Principal trading and other miscellaneous activities are small (about 5% of net revenue). The firm derives about 70% of its net revenue from the US and 30% from international markets.
<h3>Interactive Brokers Gr: A Financial Overview</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Interactive Brokers Gr's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 18.1%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Interactive Brokers Gr's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 7.68%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Interactive Brokers Gr's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.56%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Interactive Brokers Gr's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.13%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Interactive Brokers Gr's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

IBKR

Peeling Back The Layers: Exploring Interactive Brokers Gr Through Analyst Insights

Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) showcased a new product Wednesday that it claims has superior energy efficiency and reduces operational costs for <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence (AI) servers</a>.
Marvell Ara — described as a three-nanometer, 1.6 Terabits per second Pulse Amplitude Modulation 4 (PAM4) interconnect platform with 200 Gigabits per second <a href="https://www.benzinga.com/pressreleases/24/12/n42290742/marvell-unveils-industrys-first-3nm-1-6-tbps-pam4-interconnect-platform-to-scale-accelerated-infra" target="_blank" rel="noreferrer noopener">electrical and optical interfaces</a> — &#8220;sets a new industry standard,&#8221; Vice President Xi Wang <a href="https://www.benzinga.com/pressreleases/24/12/n42290742/marvell-unveils-industrys-first-3nm-1-6-tbps-pam4-interconnect-platform-to-scale-accelerated-infra">stated</a>.
Ara reduces 1.6 Tbps optical module power by over 20%. It will be available for select customers from the first quarter 2025.
Also Read: <a href="https://www.benzinga.com/government/regulations/24/12/42265847/biden-targets-china-with-new-chip-restrictions-nvidia-slides" target="_blank" rel="noreferrer noopener">Biden Targets China With New Chip Restrictions, Nvidia Slides</a> 
On Tuesday, Marvell Technology announced a five-year <a href="https://www.benzinga.com/24/12/42270388/marvell-and-aws-deepen-collaboration-on-cloud-and-ai-solutions-driving-stock-surge-ahead-of-q3-earnings" target="_blank" rel="noreferrer noopener">expanded partnership with</a> Amazon.com Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) cloud unit, Amazon Web Services, Inc . 
The collaboration focused on leveraging cloud infrastructure and driving advancements in data solutions.
Marvell Technology stock has gained 68% year-to-date as a critical supplier of semiconductor solutions for data centers, AI infrastructure, and networking.
DZ BANK AG,&nbsp;California Public Employees Retirement System,&nbsp;UBS Group AG,&nbsp;Invesco Ltd, and&nbsp;T. Rowe Price Associates Inc&nbsp;ramped stakes in Marvell Technology in <a target="_blank" href="https://www.benzinga.com/markets/equities/24/12/42260202/goldman-sachs-morgan-stanley-bank-of-montreal-cut-positions-in-marvell-technology-invesco-t-rowe-price-doubled-down" rel="noreferrer noopener">the third quarter</a>. Meanwhile,&nbsp;Morgan Stanley,&nbsp;Bank of Montreal Can,&nbsp;Clearbridge Investments, LLC, and&nbsp;Goldman Sachs&nbsp;reduced their exposure to the stock.
Analyst&nbsp;Blayne Curtis finds Marvell Technology <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41896181/nancy-pelosis-stock-pick-broadcom-and-nvidia-among-other-key-ai-stock-poised-for-chip-boom-says-analyst" rel="noreferrer noopener">well-positioned to tap</a> the&nbsp;AI chip frenzy.
Price Action: MRVL stock is up 0.72% at $97.57 at last check Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/media/24/12/42269848/amazons-aws-ceo-teases-major-ai-advancements" target="_blank" rel="noreferrer noopener">Amazon&#8217;s AWS CEO Teases Major AI Advancements</a></li>
</ul>
Image: Shutterstock

Tech

AMZN

MRVL

Marvell Unveils New Platform, Targets Growing AI Bandwidth Demands

Canopy Growth Corporation (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WEED#TSX">WEED</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) and Acreage Holdings, Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRG#CSE">ACRG</a>, ACRG.B.U))(OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/ACRHF#OTCQX">ACRHF</a>, ACRDF)) announced Monday that Canopy USA, LLC will complete its acquisition of Acreage on or around Dec. 9, 2024.
The Canadian cannabis giant announced its plans to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/19/06/13951090/canopy-shareholders-approve-acreage-deal-legalization-in-focus">acquire</a> Acreage for $3.4 billion in 2019. Initially, the deal was to be undertaken should the U.S. legalize&nbsp;marijuana on a federal level. That deal was later restructured.
The deal outlined the plan to acquire all Class E subordinate voting shares of Acreage. This acquisition will follow the purchase of the Class D shares of Acreage, based on an agreement from October 24, 2022. After both acquisitions are completed, Canopy USA will own all shares of Acreage.
Acreage pointed out in November that the move could leave holders of Acreage's Class E shares (fixed shares) with nothing if Canopy's stock price remains <a href="https://www.benzinga.com/24/11/42196557/canopy-usas-acquisition-of-acreage-could-mean-loss-for-some-shareholders-heres-why">below $5 when the deal closes</a>.
Canopy Growth's shares traded 6.71% lower at $3.545 per share at the time of writing on Tuesday December 3. Acreage's shares traded 11.63% higher at $0.12 per share.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39185620/acreage-announces-10m-private-placement-of-units-ahead-of-acquisition-by-canopy">Acreage Announces $10M Private Placement Of Units Ahead Of Acquisition By Canopy</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
Canopy USA &#8211; Canopy Growth‘s strategy for capturing the U.S. cannabis market &#8211; was created in 2022. A new U.S.-domiciled holding company is set to streamline the company's entry into the US market by allowing it to acquire Acreage as well as two other cannabis companies – Wana Brands and Jetty – while also holding a minority stake in TerrAscend. Corp. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TSND#TSX">TSND</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TSNDF#OTCQX">TSNDF</a>).
Canopy USA <a href="https://www.benzinga.com/markets/cannabis/24/10/41251114/cannabis-giant-canopy-expands-us-presence-with-acquisition-of-top-edibles-brand-what-it-means-fo">completed</a> its acquisition of Wana in October, and roughly 75% of the shares of cannabis edibles producer, Lemurian, Inc. (Jetty) as <a href="https://www.benzinga.com/markets/cannabis/24/06/39166300/canopy-growth-doubles-down-on-its-usa-strategy-announces-exercise-of-acreage-options">announced in June 2024.</a>
Canopy Growth&#8217;s newly appointed CEO Luc Mongeau, who succeeds David Klein effective Jan. 6, 2025, will continue his legacy by expanding the company&#8217;s influence in the U.S.
Read Also: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/42162875/canopy-growths-german-subsidiary-teams-up-with-portugals-gro-vida-to-expand-medical-cannabis-supply">Canopy Growth&#8217;s German Subsidiary Teams Up With Portugal&#8217;s Gro-Vida To Expand Medical Cannabis Supply</a></li>
</ul>

ACRDF

ACRHF

CSE:ACRG

TSNDF

TSX:TSND

TSX:WEED

WEED

Canopy Growth Set To Complete Acreage Acquisition, Leaving Some Shareholders Potentially Open To Losses

Boston Scientific's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) short percent of float has fallen 14.77% since its last report. The company recently reported that it has 11.02 million shares sold short, which is 0.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.92 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Boston Scientific Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733258722_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Boston Scientific has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Boston Scientific's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Boston Scientific's peer group average for short interest as a percentage of float is 4.05%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

(BSX) - Analyzing Boston Scientific's Short Interest

LGMK

LogicMark 13D/Amended Filing Shows Winvest Investment Fund Management Corp Dissolved Stake In The Co As Of Nov 22

Estee Lauder Cos's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) short percent of float has risen 55.76% since its last report. The company recently reported that it has 7.86 million shares sold short, which is 3.38% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.3 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Estee Lauder Cos Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733258716_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Estee Lauder Cos has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Estee Lauder Cos's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Estee Lauder Cos's peer group average for short interest as a percentage of float is 5.34%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Estee Lauder Cos's Recent Short Interest

HCA Healthcare's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) short percent of float has risen 14.39% since its last report. The company recently reported that it has 2.97 million shares sold short, which is 1.59% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>HCA Healthcare Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733258711_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for HCA Healthcare has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing HCA Healthcare's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, HCA Healthcare's peer group average for short interest as a percentage of float is 4.17%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into HCA Healthcare's Recent Short Interest

ORIS

Oriental Rise Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 39%

Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) shares are trading higher Tuesday. Amazon Web Services made a slew of announcements at its re:Invent 2024 conference, including the general availability of Trainium2, new database capabilities, Bedrock updates and new foundation models. Here&#8217;s what <a href="https://www.benzinga.com/pressreleases/24/12/b42296819/aws-trainium2-instances-now-generally-available">you need to know</a>.
What To Know: Amazon&#8217;s biggest conference of the year, AWS re:Invent 2024, kicked off this week with sessions set to run through Friday.
Amazon Web Services CEO&nbsp;<a href="https://www.linkedin.com/in/ACoAAAAIod8BxUdn-sU2ASLUVB0gAwBYjdhypOE"></a>Matt Garman&nbsp;on Tuesday gave his first keynote&nbsp;since taking the helm of AWS in June. The company announced the general availability of its Trainium2 chip and brought Benoit Dupin, senior director of machine learning and AI at Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), on stage. 
Amazon and Apple have been working together for years. Dupin highlighted some of the success the companies have shared and suggested on stage that Apple will&nbsp;use Amazon's Trainium2 chip to pre-train its&nbsp;models, <a href="https://www.cnbc.com/2024/12/03/apple-says-it-uses-amazons-custom-ai-chips-.html">per</a> CNBC.
Amazon said its Trainium2 chip offers 30% to 40% better price performance than the current generation and is purpose-built to support the largest generative AI workloads for both training and inference.
Amazon also announced new features that make Amazon S3 Tables the first cloud object store with fully managed support for Apache Iceberg for faster analytics. The new features also include the ability to automatically generate queryable metadata, helping to simplify data discovery.
Check This Out: <a href="https://www.benzinga.com/24/12/42265010/amazon-and-walmart-dominate-black-friday-as-online-sales-soar-146">Amazon And Walmart Dominate Black Friday As Online Sales Soar 14.6%</a>
Amazon further introduced new capabilities for Amazon Aurora and Amazon DynamoDB to support customers&#8217; demanding workloads. Amazon Aurora is a cloud-native relational database that delivers the performance and capability of a high-end commercial database, with the flexibility and cost-effectiveness of an open-source database. 
Amazon also announced new capabilities for its AI building and scaling service Amazon Bedrock that helps customers prevent factual errors, direct multiple AI-powered agents and create smaller, task-specific models. 
Amazon and GitLab Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) announced an integrated offering that brings together GitLab Duo with Amazon Q to provide a seamless AI-powered developer experience that combines DevSecOps workflows with Amazon Q autonomous agents to help companies deliver secure software more quickly.
One of the latest announcements from the re:Invent conference is Amazon&#8217;s new generation of foundation models called Amazon Nova. The following models will be available in Amazon Bedrock: 
<ul>
<li>Amazon Nova Micro, Lite &amp; Pro: very fast, text-to-text model</li>
</ul>
<ul>
<li>Amazon Nova Premier:&nbsp;multi-modal models that can process text, images and videos to generate text </li>
</ul>
<ul>
<li>Amazon Nova Canvas:&nbsp;additional model that generates studio-quality images</li>
</ul>
<ul>
<li>Amazon Nova Reel:&nbsp;additional model that generates studio-quality videos</li>
</ul>
&#8220;Inside Amazon, we have about 1,000 generative AI applications in motion, and we&#8217;ve had a bird&#8217;s-eye view of what application builders are still grappling with,&#8221; said Rohit Prasad, SVP of Amazon Artificial General Intelligence. 
&#8220;Our new Amazon Nova models are intended to help with these challenges for internal and external builders, and provide compelling intelligence and content generation while also delivering meaningful progress on latency, cost-effectiveness, customization, Retrieval Augmented Generation (RAG), and agentic capabilities.&#8221;
Amazon&#8217;s AWS re:Invent 2024 event is ongoing and further updates will likely be announced throughout the week.
AMZN Price Action: <a href="http://benzinga.com/quote/amzn">Amazon shares</a> were up 0.89% at $212.58 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/12/42299162/us-stocks-pause-south-korea-etfs-fall-on-political-turmoil-oil-prices-rise-above-70-whats-driving-markets-tuesday">US Stocks Pause, South Korea ETFs Fall On Political Turmoil, Oil Prices Rise Above $70: What&#8217;s Driving Markets Tuesday?</a></li>
</ul>
Photo: courtesy of Amazon.

AAPL

GTLB

Amazon Stock Moves Higher As AWS Unveils New AI Advancements: What You Need To Know

Joe Birkholz Joins Company as Chief Risk Officer
Alerus Financial Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRS#NASDAQ">ALRS</a>) announced Jon Hendry, Executive Vice President and Chief Technology Officer, will retire at year end. As part of his planned succession, he will transition his responsibilities to Karin Taylor, who will assume the role of Executive Vice President and Chief Operating Officer, effective January 1, 2025. In addition, Joe Birkholz has joined the company as Chief Risk Officer.

Management

ALRS

Alerus Financial Names Karin Taylor Chief Operating Officer, Effective January 1, 2025

Macro Notification

General

South Korea Opposition Party Calls On Yoon To Step Down

Guidance

AT&T Expects To No Longer Provide Copper Based Services Across Majority Of Footprint By 2029 End

Credo Technology Group Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) shares are trading higher Tuesday following the announcement of its second-quarter fiscal 2025 financial results, which significantly exceeded expectations. Here&#8217;s<a href="https://www.benzinga.com/quote/CRDO/news"> what you need to know.</a>
What To Know: On Monday, Credo reported revenue of $72.0 million, a 21% increase sequentially and a 64% year-over-year rise, exceeding the consensus estimate of $66.789 million. Credo's adjusted earnings per share came in at 7 cents, outperforming the consensus estimate of 5 cents by 40%.
The company achieved a GAAP gross margin of 63.2% and a non-GAAP gross margin of 63.6%. Credo also reported $383.0 million in cash and short-term investments.
Looking ahead, Credo issued its outlook projecting revenues between $115 million and $125 million, higher than analysts&#8217; prior expectations of $86.042 million. The company anticipates non-GAAP gross margins to remain at 61.0% to 63.0%, alongside controlled operating expenses between $42.0 million and $44.0 million.
Credo's CEO, Bill Brennan, attributed the company's success to its strategic positioning within the rapidly growing AI and data infrastructure markets. The CEO noted that the second quarter marked a turning point for Credo, with demand for its products surpassing projections. This growth is driven by accelerating AI deployments and strengthening customer relationships.
Analyst Updates: B of A Securities raised its price target from $27 to $80 and upgraded the stock to a "Buy" rating. Barclays followed suit, raising its price target to $80, while Needham increased its price target from $43 to $70.
CRDO Price Action: Credo shares were up 46.8% at $70.17 at the time of writing, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1733167806337199"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03140055/Screenshot-2024-12-03-140030-1024x535.png" alt="" class="wp-image-675156" style="width:530px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03140055/Screenshot-2024-12-03-140030-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03140055/Screenshot-2024-12-03-140030-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03140055/Screenshot-2024-12-03-140030-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03140055/Screenshot-2024-12-03-140030.png 1165w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42299448/marvell-stock-in-bullish-territory-ahead-of-q3-earnings-analysts-see-more-upside">Marvell Stock Builds Momentum Ahead Of Q3 Earnings</a></li>
</ul>
Image via Credosemi.

Credo Technology Group Shares Are On The Rise Today: What's Going On?

WIIM

SNAP

Snap shares are trading higher. Guggenheim reiterated a Buy rating on the stock.

Looking into the current session, Medtronic Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) shares are trading at $85.62, after a 1.06% decrease. Over the past month, the stock fell by 4.53%, but over the past year, it actually increased by 8.32%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1733257847_0.png" alt="Past Year Chart" />

<h3>A Look at Medtronic P/E Relative to Its Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 69.67 in the Health Care Equipment &amp; Supplies industry, Medtronic Inc. has a lower P/E ratio of 26.46. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1733257847_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: Medtronic

When we think about financial success, the first thing that comes to mind for many people is having a lot of money. However, according to a recent Empower survey, most Americans do not believe that having money is the most crucial component of success. Instead, 59% of people say happiness – being able to spend money on things that bring them joy – truly defines success.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>
The results of Empower&#8217;s study challenge the widely held belief that having a sizable bank account is the key to financial success. Just 27% of Americans believe that having money is the best indicator of success. Most people believe that living a fulfilling life with your money is more important than how much money you have overall. This includes taking care of your health, having enough free time to engage in activities and being able to spend money on things that bring you joy.
<h2 class="wp-block-heading">Happiness Over Wealth</h2>
For many Americans, financial success is tied to happiness, not just wealth. About 59% of those surveyed said that having enough money to enjoy life – whether traveling, dining out or simply being able to afford small treats – is their number one indicator of success. In the meantime, 35% of respondents cited having enough free time to pursue their passions and the same proportion cited physical health as a key indicator of success.
Rebecca Rickert, head of communications at Empower, explained it well to CNBC: &#8220;Americans are equating success with happiness as to what money can buy.&#8221; The emphasis is not on accumulating wealth but on what that money can do to improve daily life.
See Also: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a>
<h2 class="wp-block-heading">The Reality of Living Paycheck to Paycheck</h2>
Another reason <a href="https://www.benzinga.com/personal-finance/24/02/36960367/average-person-believes-financial-happiness-comes-with-a-1-2-million-price-tag-revealing-money-c">happiness matters</a> more than wealth might be because many Americans are focused on just getting by. A separate study by Bank of America found that almost half of survey respondents said they're <a href="https://www.benzinga.com/money/how-to-stop-living-paycheck-to-paycheck">living paycheck to paycheck</a>. Even higher-income households, including 20% of those making over $150,000 a year, report struggling with high expenses that leave them little extra to save.
These pressures – made worse by rising costs and inflation – make it hard for many to think about wealth in the traditional sense. Instead, financial success becomes about finding some room to breathe: being able to pay bills on time, saving a bit for the future and having a chance to spend on something that makes life enjoyable.
Trending: Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a>
<h2 class="wp-block-heading">Where do You Stand?</h2>
According to recent data from the U.S. Census Bureau, to be in the top 10% of earners in the U.S., your household must <a href="https://www.benzinga.com/24/11/41889242/are-you-in-the-top-10-heres-what-it-really-takes-to-make-the-cut-and-rank-among-the-richest">make $191,406</a> or more annually. However, financial success isn&#8217;t just about reaching this number. Age and location significantly influence what is considered &#8220;top tier.&#8221;
For example, peak earning years for the top 10% of households are generally in the 45-54 age range, where an annual income of $255,000 places you at the top. The threshold for the top 10% is significantly greater in high-cost states like California, at about $341,276 annually than in places like Mississippi, where it is $189,922, as the location is an important factor.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/62-years-old-with-1-mil-saved">I&#8217;m 62 Years Old And Have $1.2 Million Saved. Is This Enough to Retire Stress-Free?</a></li>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
</ul>

Personal Finance

Most Americans Don't See Wealth As The Key To Financial Success – Here's What Matters More To 59% Of Them

<a href="https://www.yna.co.kr/view/AKR20241204015800001?input=tw" title="https://www.yna.co.kr/view/AKR20241204015800001?input=tw">https://www.yna.co.kr/view/AKR20241204015800001?input=tw</a>

Regional Management shares are trading higher after the company announced a $30 million stock repurchase program.

Deep-pocketed investors have adopted a bullish approach towards Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ROKU usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Roku. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 53% leaning bullish and 38% bearish. Among these notable options, 5 are puts, totaling $206,820, and 8 are calls, amounting to $362,820.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $35.0 to $100.0 for Roku over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Roku options trades today is 1416.18 with a total volume of 4,185.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Roku's big money trades within a strike price range of $35.0 to $100.0 over the last 30 days.
<h3>Roku Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733256948_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ROKU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$0.77</td>
<td>$0.76</td>
<td>$0.77</td>
<td>$95.00</td>
<td>$92.7K</td>
<td>3.6K</td>
<td>1.1K</td>
</tr>
<tr>
<td>ROKU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$7.25</td>
<td>$7.15</td>
<td>$7.15</td>
<td>$80.00</td>
<td>$62.9K</td>
<td>2.5K</td>
<td>105</td>
</tr>
<tr>
<td>ROKU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$17.75</td>
<td>$17.6</td>
<td>$17.75</td>
<td>$90.00</td>
<td>$56.8K</td>
<td>190</td>
<td>36</td>
</tr>
<tr>
<td>ROKU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$19.5</td>
<td>$18.85</td>
<td>$19.5</td>
<td>$65.00</td>
<td>$50.7K</td>
<td>375</td>
<td>26</td>
</tr>
<tr>
<td>ROKU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.2</td>
<td>$1.09</td>
<td>$1.2</td>
<td>$90.00</td>
<td>$48.0K</td>
<td>7.7K</td>
<td>560</td>
</tr>
</tbody>
</table>

<h3>About Roku</h3>
Roku enables consumers to stream television programming. It has more than 80 million streaming households and provided well over 100 billion streaming hours in 2023. Roku is the top streaming operating system in the US, reaching more than half of broadband households, according to the company. Roku's OS is built into streaming devices and televisions that Roku sells and on connected televisions from other manufacturers that license Roku's name and software. Roku also operates the Roku Channel, a free, ad-supported streaming television platform that offers a mix of on-demand and live television programming. Roku generates revenue primarily from selling devices, licensing, and advertising, and it receives fees from subscription streaming platforms that sell subscriptions through Roku.
Having examined the options trading patterns of Roku, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Roku</h3>
<ul>
<li>Currently trading with a volume of 2,919,535, the ROKU's price is down by -1.64%, now at $75.79. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 72 days.</li>
</ul>
<h3>What Analysts Are Saying About Roku</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $81.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from UBS lowers its rating to Neutral with a new price target of $73. 
&#x2A; An analyst from Baird has elevated its stance to Outperform, setting a new price target at $90. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Roku, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

ROKU

Roku Unusual Options Activity

Investors with a lot of money to spend have taken a bearish stance on Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GILD, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 8 options trades for Gilead Sciences.
This isn't normal.
The overall sentiment of these big-money traders is split between 37% bullish and 62%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $103,960, and 7, calls, for a total amount of $499,525.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $75.0 to $97.5 for Gilead Sciences over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Gilead Sciences's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Gilead Sciences's whale activity within a strike price range from $75.0 to $97.5 in the last 30 days. 
<h3>Gilead Sciences 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733256943_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GILD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.65</td>
<td>$2.5</td>
<td>$2.61</td>
<td>$95.00</td>
<td>$236.6K</td>
<td>11.5K</td>
<td align="right">920</td>
</tr>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$2.3</td>
<td>$2.21</td>
<td>$2.3</td>
<td>$94.00</td>
<td>$103.9K</td>
<td>1.2K</td>
<td align="right">883</td>
</tr>
<tr>
<td>GILD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$1.91</td>
<td>$1.9</td>
<td>$1.9</td>
<td>$94.00</td>
<td>$90.2K</td>
<td>622</td>
<td align="right">493</td>
</tr>
<tr>
<td>GILD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$7.1</td>
<td>$7.0</td>
<td>$7.0</td>
<td>$90.00</td>
<td>$52.5K</td>
<td>936</td>
<td align="right">76</td>
</tr>
<tr>
<td>GILD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$19.25</td>
<td>$19.25</td>
<td>$19.25</td>
<td>$75.00</td>
<td>$38.5K</td>
<td>3.2K</td>
<td align="right">20</td>
</tr>
</tbody>
</table>

<h3>About Gilead Sciences</h3>
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
<h3>Where Is Gilead Sciences Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 2,570,655, the GILD's price is down by -0.41%, now at $93.63. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 63 days.</li>
</ul>
<h3>Expert Opinions on Gilead Sciences</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $97.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Gilead Sciences, targeting a price of $105. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Gilead Sciences, targeting a price of $96. 
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Gilead Sciences, maintaining a target price of $105. 
&#x2A; An analyst from RBC Capital has decided to maintain their Sector Perform rating on Gilead Sciences, which currently sits at a price target of $84. 
&#x2A; An analyst from Baird has decided to maintain their Neutral rating on Gilead Sciences, which currently sits at a price target of $95. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Gilead Sciences, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

GILD

Looking At Gilead Sciences's Recent Unusual Options Activity

Trump Media Stock Price Depends On The Presidential Campaign

'Uncancellable' Trump Media Preannounces Meager Revenue

Trump Media & Technology Group Is Upgraded To A Buy At Current Price (Rating Upgrade)

Best And Worst Performers Since August 5, 2024

Trump Media: Bet On Collapse

Trump Media & Technology Group: Look Out Below

Sell Trump Media & Technology Group Warrants

Shorting Trump Media & Technology Group Is A Fantastic Investment

Trump Media: This Is The Inflection Point

Trump Media & Technology Group: Donald Trump's Win Doesn't Negate This As The Perfect Short

AFRM

ALLY

BIRK

CAVA

CELH

DLTR

DUOL

FIVE

MRNA

PINS

PLTR

RTMVF

RTMVY

SIRI

WOLF

Autohome Inc. American Depositary Shares, each representing four class A ordinary shares.

Autohome

Baidu, Inc. - American Depositary Shares, each representing 8 ordinary share

Baidu

Bilibili Inc. - American Depositary Shares

Bilibili

KANZHUN LIMITED - American Depository Shares

Kanzhun

CarGurus

Cars.com

Trump Media & Technology Group Corp. - Common Stock

Trump Media & Technology

Alphabet

Grindr

Match Group

Pinterest

QuinStreet

Reddit

Rumble

Snap

Tripadvisor

Weibo Corporation - American Depositary Shares

Weibo

WEBTOON Entertainment Inc. - Common stock

Webtoon Entertainment

Yelp

JOYY

Ziff Davis

ZoomInfo Technologies Inc. - Common Stock

ZoomInfo Technologies

先週、これらの中型株は最も優れた業績を発揮しました。あなたのポートフォリオには含まれていますか？
<ol>
<li>米国株式市場（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>）の株価は、同社のTempus ECG-AFデバイスが米国食品医薬品局（FDA）の510（k）の認可を取得したと発表したことを受けて30.43％上昇しました。このデバイスは、心房細動/フラッターのリスクが高いと考えられる患者を特定するのにAIが用いられています。</li>
<li>米国株式市場（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>）の株価は、アジアの大手家電バッテリーパックメーカーであるElentecがEnovix Corporationと覚書（MOU）に調印したことを発表した後、29.70％上昇しました。</li>
<li>Grindr Inc. （NYSE：<a class="ticker" href="https://www.benzinga.com/stock/GRND#NYSE">GRND</a>）の株式は、同社が<a href="https://www.benzinga.com//node/39504431" target="_blank" rel="noreferrer noopener">初の投資家向け説明会</a>を先取りして、今年の収益見通しを引き上げたことを受けて27.50％急伸しました。</li>
<li>Trump Media &amp; Technology Group Corp. （NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/DJTWW#NASDAQ">DJTWW</a>）の株式ワラントは、同社が2024年6月20日と21日に<a href="https://www.benzinga.com//node/39453772" target="_blank" rel="noreferrer noopener">現金による権利行使によって6940万ドル以上を受領することを期待している</a>と発表した後、18.33％上昇しました。</li>
<li>Credo Technology Group（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>）の株価は、TD Cowenが同社の株をBuyに格上げし、<a href="https://www.benzinga.com/quote/CRDO/analyst-ratings" target="_blank" rel="noreferrer noopener">株価目標を24ドルから35ドルに引き上げたことを受けて18.30％急騰しました</a>。</li>
<li>Tecnoglass Inc.（NYSE：<a class="ticker" href="https://www.benzinga.com/stock/TGLS#NYSE">TGLS</a>）の株価は、同社が取締役会で戦略的な選択肢を検討していることを発表した後、17.90％上昇しました。また、同社は<a href="https://www.benzinga.com//node/39489521" target="_blank" rel="noreferrer noopener">2024年のFY24業績見通しを再確認しました</a>。</li>
<li>STAAR Surgical Company（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/STAA#NASDAQ">STAA</a>）の株価は、16.55％上昇しています。</li>
<li>RXO Inc.（NYSE：<a class="ticker" href="https://www.benzinga.com/stock/EXO#NYSE">EXO</a>）の株価は、先週、UPSから<a href="https://www.benzinga.com//node/39453065" target="_blank" rel="noreferrer noopener">Coyote Logisticsが買収されると発表されたことを受けて16.22%上昇しました。</a></li>
<li>Global-E Online Ltd（NASDAQ：<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>）の株価は先週、16.21%上昇しました。</li>
<li>SentinelOne Inc（NYSE：<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>）の株価は、DA Davidsonが同社の株に対するNeutral投資評価を維持し、株価予測を17ドルから18.5ドルに引き上げたことを受けて15.47%上昇しました。</li>
</ol>

Comments

Trump Media & Technology

ニュース

最新ニュース Trump Media & Technology (NASDAQ:DJTWW) 株価情報

月曜日, 7 01, 2024

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル